医学
卵巢癌
类有机物
药品
肿瘤科
免疫疗法
靶向治疗
化疗
癌症
抗药性
内科学
佐剂
药物基因组学
癌症研究
药理学
微生物学
生物
遗传学
作者
Hongfang Liu,Bai-Rong Xia,Muqing Jin,Ge Lou
标识
DOI:10.1007/s12094-019-02276-8
摘要
Abstract Ovarian cancer is the most common malignant tumors of the female reproductive system, and its standard treatments are cytoreductive surgery and platinum-based adjuvant chemotherapy. Great advances have been achieved in novel treatment strategies, including targeted therapy and immunotherapy. However, ovarian cancer has the highest mortality rate among gynecological tumors due to therapeutic resistance and the gap between preclinical data and actual clinical efficacy. Organoids are a 3D culture model that markedly affects gene analysis, drug screening, and drug sensitivity determination of tumors, especially when used in targeted therapy and immunotherapy. In addition, organoid can lead to advances in the preclinical research of ovarian cancer due to its convenient cultivation, good genetic stability, and high homology with primary tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI